2025 Clinical Trials Patients 
Miss Marijuana
FEBRUARY 7, 2025
Whether you’re a medical professional, a patient, or just someone interested in natural wellness, understanding how CBD and THC differ can seriously change how you think about healing. As of 2025 , the legal status of THC and CBD is still evolving. Did you know that over 33% of Americans have tried CBD products for health reasons?
Miss Marijuana
FEBRUARY 1, 2025
A 2024 study found that 67% of cancer patients using medical marijuana saw major improvements in their quality of life. Clinical trials are currently underway, so keep an eye out for new findings. Appetite Stimulation Methods Loss of appetite is another common symptom, especially for cancer patients undergoing treatment.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
DECEMBER 23, 2021
billion by 2025. The market sizing section provides forecasts on the estimated sales of the three most lucrative cannabinoid pharmaceuticals – from 2021-2025 – including Epidiolex, Sativex and Dronabinol. Global surveys of cannabis users indicate that around 40% of users have some medical component to their usage.
Puff Puff Post
DECEMBER 28, 2018
A sample of 120 patients aged between 5 and 29 years old with mild to severe autism are currently being given two different cannabis oil formulas or placebo. This is on par with the cost currently seen for those afflicted with ADHD and diabetes, with predictions for the cost to skyrocket further by 2025.
Cannabis Law Report
JUNE 25, 2021
billion in 2025 at a CAGR of 14%. EMA also regulates and supervises the drug quality, check for the intended use of the drug and whether the drug is meeting the requirement of clinical trial. The market is expected to reach $2.72 The skin cancer drugs market consists of sales of skin cancer drugs.
Cannabis Law Report
NOVEMBER 16, 2021
As cleared by the FDA, the primary endpoint of the Phase 2 double-blind, placebo-controlled clinical trial is to achieve a reduction in the circulating levels of tumor necrosis factor-alpha (TNF-?), The secondary measures will be the safety, tolerability, and pharmacokinetics in this population of patients.
Cannabis Law Report
JULY 15, 2022
“It’s very important from our perspective to ensure that the Australian patient gets medicine first. The first medicinal cannabis ‘mother’ plants are expected to be imported from Israel within a month, with manufacturing scheduled to begin within the first half of this year, to supply 5,000 Australian patients.
Expert insights. Personalized for you.
Let's personalize your content